Header Logo

Connection

Ankeet Bhatt to Humans

Back to Details
This is a "connection" page, showing publications Ankeet Bhatt has written about Humans.
Ankeet Bhatt
Connection Strength
2.445
Humans
  1. Virtual Care Team Guided Management of Patients With Heart Failure During?Hospitalization. J Am Coll Cardiol. 2023 May 02; 81(17):1680-1693.
    View in: PubMed
    Score: 0.061
  2. Impact of COVID-19 on?Heart?Failure Clinical?Trials: Insights From the Heart?Failure Collaboratory. JACC Heart Fail. 2023 Feb; 11(2):254-257.
    View in: PubMed
    Score: 0.061
  3. Evaluating Implementation Approaches in Heart?Failure: Ripe for rEVOLUTION. JACC Heart Fail. 2023 01; 11(1):15-18.
    View in: PubMed
    Score: 0.060
  4. Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care. J Card Fail. 2023 Feb; 29(2):138-146.
    View in: PubMed
    Score: 0.060
  5. Building a Curriculum for the Cardiovascular Implementation Scientist. J Am Coll Cardiol. 2022 09 06; 80(10):1023-1027.
    View in: PubMed
    Score: 0.059
  6. The cardiovascular legacy of the COVID-19 pandemic. Eur Heart J. 2022 Sep 01; 43(33):3179-3181.
    View in: PubMed
    Score: 0.059
  7. Evaluating Digital Technologies for Implementation Science. J Card Fail. 2022 10; 28(10):1497-1499.
    View in: PubMed
    Score: 0.059
  8. Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25?000 Medicare beneficiaries. Eur J Heart Fail. 2022 Sep; 24(9):1506-1515.
    View in: PubMed
    Score: 0.058
  9. Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. J Am Heart Assoc. 2022 05 03; 11(9):e024451.
    View in: PubMed
    Score: 0.058
  10. Prioritizing prevention of de novo and worsening chronic heart failure. Eur J Heart Fail. 2022 04; 24(4):653-656.
    View in: PubMed
    Score: 0.057
  11. Personalizing Comprehensive Disease-Modifying Therapy: Obstacles and Opportunities. JACC Heart Fail. 2022 02; 10(2):85-88.
    View in: PubMed
    Score: 0.056
  12. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. J Card Fail. 2021 10; 27(10):1073-1081.
    View in: PubMed
    Score: 0.056
  13. Adherence to Evidence-Based Therapies in Heart Failure: Deepening the Implementation Divide. JACC Heart Fail. 2021 12; 9(12):887-889.
    View in: PubMed
    Score: 0.055
  14. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail. 2022 01; 28(1):93-112.
    View in: PubMed
    Score: 0.055
  15. Prioritizing Dissemination and Implementation Science in Cardiometabolic Medicine: CONNECTing the Dots. JAMA. 2021 07 27; 326(4):311-313.
    View in: PubMed
    Score: 0.055
  16. Evidence-Based Prescribing and Polypharmacy for Patients With Heart Failure. Ann Intern Med. 2021 08; 174(8):1165-1166.
    View in: PubMed
    Score: 0.055
  17. Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial. Eur J Heart Fail. 2021 09; 23(9):1518-1524.
    View in: PubMed
    Score: 0.055
  18. Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization. J Card Fail. 2021 09; 27(9):1027-1030.
    View in: PubMed
    Score: 0.054
  19. Accuracy of ICD-10 Diagnostic Codes to Identify COVID-19 Among Hospitalized Patients. J Gen Intern Med. 2021 08; 36(8):2532-2535.
    View in: PubMed
    Score: 0.054
  20. Influenza vaccination: a 'shot' at INVESTing in cardiovascular health. Eur Heart J. 2021 05 21; 42(20):2015-2018.
    View in: PubMed
    Score: 0.054
  21. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study. Eur J Heart Fail. 2021 07; 23(7):1191-1201.
    View in: PubMed
    Score: 0.054
  22. Reply: Improving Heart Failure Therapeutics: Thinking Outside the Pillbox? JACC Heart Fail. 2021 04; 9(4):320-321.
    View in: PubMed
    Score: 0.054
  23. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021 01; 9(1):65-73.
    View in: PubMed
    Score: 0.053
  24. Discovery and care innovation amidst a pandemic. Eur J Heart Fail. 2020 12; 22(12):2202-2204.
    View in: PubMed
    Score: 0.053
  25. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory. JACC Heart Fail. 2021 01; 9(1):1-12.
    View in: PubMed
    Score: 0.053
  26. Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients? J Am Coll Cardiol. 2020 11 24; 76(21):2574-2575.
    View in: PubMed
    Score: 0.052
  27. For vaptans, as for life, balance is better. Eur J Heart Fail. 2021 05; 23(5):751-753.
    View in: PubMed
    Score: 0.052
  28. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 Jul 21; 76(3):280-288.
    View in: PubMed
    Score: 0.051
  29. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. Eur J Heart Fail. 2020 06; 22(6):1022-1031.
    View in: PubMed
    Score: 0.050
  30. Growing Mismatch Between Evidence Generation and Implementation in Heart Failure. Am J Med. 2020 05; 133(5):525-527.
    View in: PubMed
    Score: 0.049
  31. Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong. Eur J Heart Fail. 2020 02; 22(2):313-314.
    View in: PubMed
    Score: 0.049
  32. Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. Eur J Heart Fail. 2020 01; 22(1):164-167.
    View in: PubMed
    Score: 0.049
  33. International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. Am Heart J. 2019 12; 218:57-65.
    View in: PubMed
    Score: 0.048
  34. Influenza Vaccination in Patients With Heart Failure. Circulation. 2019 01 29; 139(5):587-589.
    View in: PubMed
    Score: 0.046
  35. Reply: Vaccination in Patients With Heart Failure: An Established Recommendation in Patients With Chronic Heart Disease. JACC Heart Fail. 2019 01; 7(1):85.
    View in: PubMed
    Score: 0.046
  36. Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. JACC Heart Fail. 2018 10; 6(10):844-855.
    View in: PubMed
    Score: 0.045
  37. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017 08; 19(8):71.
    View in: PubMed
    Score: 0.042
  38. Achieving a Maximally Tolerated ß-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? J Am Coll Cardiol. 2017 May 23; 69(20):2542-2550.
    View in: PubMed
    Score: 0.041
  39. Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. JACC Heart Fail. 2017 03; 5(3):194-203.
    View in: PubMed
    Score: 0.040
  40. Curious Crosses: Injection-Induced Lesions. Am J Med. 2017 Jan; 130(1):31-33.
    View in: PubMed
    Score: 0.039
  41. Improving operating room turnover time: a systems based approach. J Med Syst. 2014 Dec; 38(12):148.
    View in: PubMed
    Score: 0.034
  42. Strategic transformations in academic clinical medicine. Conn Med. 2014 Jun-Jul; 78(6):357-61.
    View in: PubMed
    Score: 0.033
  43. Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial. Lancet. 2023 04 01; 401(10382):1103-1114.
    View in: PubMed
    Score: 0.015
  44. Effect of Dapagliflozin on Health Status in?Patients With Preserved or Mildly?Reduced Ejection Fraction. J Am Coll Cardiol. 2023 Feb 07; 81(5):460-473.
    View in: PubMed
    Score: 0.015
  45. Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease. Int J Hematol. 2023 Jan; 117(1):90-99.
    View in: PubMed
    Score: 0.015
  46. Reply: Bounded Rationality and Clinical Guidance Documents for Heart Failure. JACC Heart Fail. 2022 03; 10(3):213-214.
    View in: PubMed
    Score: 0.014
  47. Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network. J Card Fail. 2022 04; 28(4):675-681.
    View in: PubMed
    Score: 0.014
  48. Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes. J Am Heart Assoc. 2022 01 04; 11(1):e022010.
    View in: PubMed
    Score: 0.014
  49. Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021 12 01; 6(12):1415-1423.
    View in: PubMed
    Score: 0.014
  50. Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circ Heart Fail. 2021 12; 14(12):e008477.
    View in: PubMed
    Score: 0.014
  51. Cost and Value in Contemporary Heart Failure Clinical Guidance Documents. JACC Heart Fail. 2022 01; 10(1):1-11.
    View in: PubMed
    Score: 0.014
  52. Hospitalization of Patients With (But Not for) Heart Failure: An Opportunity for Accelerated Guideline-Directed Medical Therapy Optimization? J Card Fail. 2021 08; 27(8):910-912.
    View in: PubMed
    Score: 0.014
  53. Prognostic Value of Natriuretic Peptides and Cardiac Troponins in COVID-19. Circulation. 2021 07 13; 144(2):177-179.
    View in: PubMed
    Score: 0.014
  54. Incidence and Outcomes of Pneumonia in Patients With Heart Failure. J Am Coll Cardiol. 2021 04 27; 77(16):1961-1973.
    View in: PubMed
    Score: 0.013
  55. Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches. Heart Fail Rev. 2021 01; 26(1):11-21.
    View in: PubMed
    Score: 0.013
  56. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 11 17; 76(20):2368-2378.
    View in: PubMed
    Score: 0.013
  57. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis. Am Heart J. 2021 02; 232:105-115.
    View in: PubMed
    Score: 0.013
  58. Practice pattern of use of high sensitivity troponin in the outpatient settings. Clin Cardiol. 2020 Dec; 43(12):1573-1578.
    View in: PubMed
    Score: 0.013
  59. A Man in His 30s With a New Continuous Murmur and Fever. JAMA Cardiol. 2020 08 01; 5(8):e203255.
    View in: PubMed
    Score: 0.013
  60. Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019. Heart Fail Clin. 2020 Oct; 16(4):433-440.
    View in: PubMed
    Score: 0.013
  61. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Am Heart J. 2018 05; 199:97-104.
    View in: PubMed
    Score: 0.011
  62. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Am J Cardiol. 2017 07 01; 120(1):98-105.
    View in: PubMed
    Score: 0.010

© 2025 Kaiser Permanente